Activated Protein C Resistance Does Not Increase Risk for Recurrent Stroke or Death in Stroke Patients

about

Activated Protein C Resistance Does Not Increase Risk for Recurrent Stroke or Death in Stroke Patients

Item

http://www.wikidata.org/entity/Q36100026

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Activated Protein C Resistance ...... ke or Death in Stroke Patients

@ast

Activated Protein C Resistance ...... ke or Death in Stroke Patients

@en

type

Item

label

Activated Protein C Resistance ...... ke or Death in Stroke Patients

@ast

Activated Protein C Resistance ...... ke or Death in Stroke Patients

@en

prefLabel

Activated Protein C Resistance ...... ke or Death in Stroke Patients

@ast

Activated Protein C Resistance ...... ke or Death in Stroke Patients

@en

P1476

Activated Protein C Resistance ...... ke or Death in Stroke Patients

@en

P2093

Christoph Thaler

http://www.w3.org/2001/XMLSchema#string

Holger Poppert

http://www.w3.org/2001/XMLSchema#string

Ina-Christine Rondak

http://www.w3.org/2001/XMLSchema#string

Markus Alexander Thaler

http://www.w3.org/2001/XMLSchema#string

Michael Schleef

http://www.w3.org/2001/XMLSchema#string

Natalie Sonntag

http://www.w3.org/2001/XMLSchema#string

Regina Feurer

http://www.w3.org/2001/XMLSchema#string

P2860

Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment

Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C

Thrombophilias in patients with ischemic stroke. Indication and calculated costs for evidence-based diagnostics and treatment

Diagnostic testing for coagulopathies in patients with ischemic stroke.

Usefulness of factor V Leiden mutation testing in clinical practice.

Cryptogenic stroke: A diagnostic challenge

Mutation in blood coagulation factor V associated with resistance to activated protein C.

Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening.

Deficiencies of proteins C, S and antithrombin and activated protein C resistance--their involvement in the occurrence of Arterial thromboses.

Factor V leiden and ischemic stroke risk: the Genetics of Early Onset Stroke (GEOS) study.

P304

e0160382

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0160382

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-08-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27508300

http://www.w3.org/2001/XMLSchema#string

P932

4980060

http://www.w3.org/2001/XMLSchema#string